BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31953505)

  • 1. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC; Nehra A; Mathur A; Rai S
    J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.
    Bennet SMP; Sundin J; Magnusson MK; Strid H; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13468. PubMed ID: 30230134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
    Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.
    Sundin J; Stridsberg M; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2018 Nov; 8(1):16821. PubMed ID: 30429499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC; Srivastava D; Ghoshal U; Misra A
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.
    Grover M; Kanazawa M; Palsson OS; Chitkara DK; Gangarosa LM; Drossman DA; Whitehead WE
    Neurogastroenterol Motil; 2008 Sep; 20(9):998-1008. PubMed ID: 18482250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
    Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.
    Ghoshal UC; Srivastava D
    World J Gastroenterol; 2014 Mar; 20(10):2482-91. PubMed ID: 24627585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth.
    Li J; Zhang R; Ma J; Tang S; Li Y; Li Y; Wan J
    Front Microbiol; 2021; 12():710940. PubMed ID: 34421869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.